Literature DB >> 15548858

Cell migration and metastasis as targets of small RNA-based molecular genetic analyses.

Eigo Suyama1, Hiroaki Kawasaki, Renu Wadhwa, Kazunari Taira.   

Abstract

Metastatic tumor cells can migrate from one place to another in the body. This involves their adherence to host cell layers and subsequent transcellular movements by a complex process, molecular basis of which are yet to be clarified. Elucidation of genes functionally involved in metastasis may lead to deeper understanding of the mechanism of cell migration, and identification and designing of metastasis-modulating strategies for cancer therapeutics. We review here cell migration in tumor metastasis and the use of small RNA-based approaches to identify functional genes. We then describe our promising novel approach that uses randomized ribozyme libraries for identification of genes involved in cell migration, a consistent feature of metastatic cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15548858     DOI: 10.1007/s10974-004-4343-7

Source DB:  PubMed          Journal:  J Muscle Res Cell Motil        ISSN: 0142-4319            Impact factor:   2.698


  52 in total

Review 1.  Genomics, gene expression and DNA arrays.

Authors:  D J Lockhart; E A Winzeler
Journal:  Nature       Date:  2000-06-15       Impact factor: 49.962

2.  Search for genes that suppress cancer metastasis.

Authors:  I J Fidler; R Radinsky
Journal:  J Natl Cancer Inst       Date:  1996-12-04       Impact factor: 13.506

3.  ROCK-I and ROCK-II, two isoforms of Rho-associated coiled-coil forming protein serine/threonine kinase in mice.

Authors:  O Nakagawa; K Fujisawa; T Ishizaki; Y Saito; K Nakao; S Narumiya
Journal:  FEBS Lett       Date:  1996-08-26       Impact factor: 4.124

4.  Identification of eIF2Bgamma and eIF2gamma as cofactors of hepatitis C virus internal ribosome entry site-mediated translation using a functional genomics approach.

Authors:  M Kruger; C Beger; Q X Li; P J Welch; R Tritz; M Leavitt; J R Barber; F Wong-Staal
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

5.  Catalytic activity of an RNA molecule prepared by transcription in vitro.

Authors:  C Guerrier-Takada; S Altman
Journal:  Science       Date:  1984-01-20       Impact factor: 47.728

6.  Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes.

Authors:  Y Hippo; M Yashiro; M Ishii; H Taniguchi; S Tsutsumi; K Hirakawa; T Kodama; H Aburatani
Journal:  Cancer Res       Date:  2001-02-01       Impact factor: 12.701

7.  Molecular classification of cutaneous malignant melanoma by gene expression profiling.

Authors:  M Bittner; P Meltzer; Y Chen; Y Jiang; E Seftor; M Hendrix; M Radmacher; R Simon; Z Yakhini; A Ben-Dor; N Sampas; E Dougherty; E Wang; F Marincola; C Gooden; J Lueders; A Glatfelter; P Pollock; J Carpten; E Gillanders; D Leja; K Dietrich; C Beaudry; M Berens; D Alberts; V Sondak
Journal:  Nature       Date:  2000-08-03       Impact factor: 49.962

8.  Genomic analysis of metastasis reveals an essential role for RhoC.

Authors:  E A Clark; T R Golub; E S Lander; R O Hynes
Journal:  Nature       Date:  2000-08-03       Impact factor: 49.962

9.  LIM kinase-2 targeting as a possible anti-metastasis therapy.

Authors:  Eigo Suyama; Renu Wadhwa; Hiroaki Kawasaki; Tomoko Yaguchi; Sunil C Kaul; Motowo Nakajima; Kazunari Taira
Journal:  J Gene Med       Date:  2004-03       Impact factor: 4.565

10.  Chemotaxis of metastatic tumor cells.

Authors:  J Varani
Journal:  Cancer Metastasis Rev       Date:  1982       Impact factor: 9.264

View more
  2 in total

Review 1.  Biomolecular gradients in cell culture systems.

Authors:  Thomas M Keenan; Albert Folch
Journal:  Lab Chip       Date:  2007-12-06       Impact factor: 6.799

2.  Combined inhibition of AXL, Lyn and p130Cas kinases block migration of triple negative breast cancer cells.

Authors:  Kinga Pénzes; Christine Baumann; István Szabadkai; László Orfi; György Kéri; Axel Ullrich; Robert Torka
Journal:  Cancer Biol Ther       Date:  2014       Impact factor: 4.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.